<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>082</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Japanese Encephalitis</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Japanese Encephalitis vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>115</observationCode>
<observationTitle>Severe allergic reaction to protamine sulfate</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to protamine sulfate.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
</contraindications>
<series>
<seriesName>Japanese Encephalitis risk 2-dose series</seriesName>
<targetDisease>Japanese Encephalitis</targetDisease>
<vaccineGroup>Japanese Encephalitis</vaccineGroup>
<seriesAdminGuidance>For adults and children, a booster dose (i.e., third dose) should be given on or after 1 year after completion of the primary JE-VC series if ongoing exposure or reexposure to JE virus is expected</seriesAdminGuidance>
<seriesAdminGuidance>JE vaccination should be considered for shorter-term (e.g., less than 1 month) travel with an increased risk for JE on the basis of planned travel duration, season, location, activities, and accommodations. See JE recommendation box 2 for more detailed information. (https://www.cdc.gov/mmwr/volumes/68/rr/rr6802a1.htm#B2_down)</seriesAdminGuidance>
<seriesAdminGuidance>JE vaccination should be considered for travel to a JE-endemic area but uncertain of specific duration of travel, destination, or activities.</seriesAdminGuidance>
<seriesAdminGuidance>Endemic Area and transmission season is determined by country.  Refer to the yellow book for a definition of the transmission season: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/japanese-encephalitis
</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>2 months</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Longer-term (e.g., 1 month or more) travel to a JE-endemic area</text>
<code>165</code>
</observationCode>
<description>Administer to persons who plan for longer-term (e.g., ? 1 month) travel to JE-endemic areas.</description>
<beginAge>2 months</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Moving to JE-endemic country to take up residence</text>
<code>173</code>
</observationCode>
<description>Administer to persons who plan to move to JE-endemic countries to take up residence.</description>
<beginAge>2 months</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Frequent travel to JE-endemic areas</text>
<code>174</code>
</observationCode>
<description>Administer to persons who frequently travel to JE-endemic areas.</description>
<beginAge>2 months</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 months - 4 days</absMinAge>
<minAge>2 months</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Japanese Encephalitis risk 2-dose series 18-64 years</seriesName>
<targetDisease>Japanese Encephalitis</targetDisease>
<vaccineGroup>Japanese Encephalitis</vaccineGroup>
<seriesAdminGuidance>For adults and children, a booster dose (i.e., third dose) should be given on or after 1 year after completion of the primary JE-VC series if ongoing exposure or reexposure to JE virus is expected</seriesAdminGuidance>
<seriesAdminGuidance>JE vaccination should be considered for shorter-term (e.g., less than 1 month) travel with an increased risk for JE on the basis of planned travel duration, season, location, activities, and accommodations. See JE recommendation box 2 for more detailed information. (https://www.cdc.gov/mmwr/volumes/68/rr/rr6802a1.htm#B2_down)</seriesAdminGuidance>
<seriesAdminGuidance>JE vaccination should be considered for travel to a JE-endemic area but uncertain of specific duration of travel, destination, or activities.</seriesAdminGuidance>
<seriesAdminGuidance>Endemic Area and transmission season is determined by country.  Refer to the yellow book for a definition of the transmission season: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/japanese-encephalitis
</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>18 years</minAgeToStart>
<maxAgeToStart>65 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Longer-term (e.g., 1 month or more) travel to a JE-endemic area</text>
<code>165</code>
</observationCode>
<description>Administer to persons who plan for longer-term (e.g., ? 1 month) travel to JE-endemic areas.</description>
<beginAge>18 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Moving to JE-endemic country to take up residence</text>
<code>173</code>
</observationCode>
<description>Administer to persons who plan to move to JE-endemic countries to take up residence.</description>
<beginAge>18 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Frequent travel to JE-endemic areas</text>
<code>174</code>
</observationCode>
<description>Administer to persons who frequently travel to JE-endemic areas.</description>
<beginAge>18 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>65 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>7 days</absMinInt>
<minInt>7 days</minInt>
<earliestRecInt>7 days</earliestRecInt>
<latestRecInt>28 days</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>12 months - 4 days</absMinInt>
<minInt>12 months</minInt>
<earliestRecInt>12 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months</beginAge>
<endAge>3 years</endAge>
<tradeName/>
<mvx/>
<volume>0.25</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>3 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Japanese Encephalitis, VC</vaccineType>
<cvx>134</cvx>
<beginAge>2 months - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
